Titan Pharmaceuticals, Inc. (TTNP) Reports Q3 Loss of $0.01
Tweet
Share
E-mailGet Alerts TTNP Hot Sheet
Join SI Premium – FREE
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) reported Q3 EPS of ($0.01), versus ($0.01) reported last year. Revenue for the quarter came in at $1.01 million, versus $3.6 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- Canadian Solar (CSIQ) Misses Q2 EPS by 66c ; Offers Guidance
- Build-A-Bear Workshop (BBW) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
